COBB CAROLE B 4

Accession 0001062993-22-002725

CIK 0001822691other

Filed

Feb 3, 7:00 PM ET

Accepted

Feb 4, 7:25 PM ET

Size

18.8 KB

Accession

0001062993-22-002725

Form 4

Period: 2022-02-02

Chief Operating Officer

Transactions

Award
Stock Option (Right to Buy)
2022-02-02+43,863→ 43,863 total
Exercise: $0.35Exp: 2026-10-21→ Common Stock (43,863 underlying)
Award
Stock Option (Right to Buy)
2022-02-02+187,831→ 187,831 total
Exercise: $0.33Exp: 2028-09-13→ Common Stock (187,831 underlying)
Award
Stock Option (Right to Buy)
2022-02-02+326,144→ 326,144 total
Exercise: $0.98Exp: 2030-12-01→ Common Stock (326,144 underlying)
Award
Stock Option (Right to Buy)
2022-02-02+26,987→ 26,987 total
Exercise: $0.50Exp: 2029-12-29→ Common Stock (26,987 underlying)
Award
Stock Option (Right to Buy)
2022-02-02+427,752→ 427,752 total
Exercise: $0.35Exp: 2025-07-22→ Common Stock (427,752 underlying)
Award
Stock Option (Right to Buy)
2022-02-02+459,264→ 459,264 total
Exercise: $0.33Exp: 2028-02-14→ Common Stock (459,264 underlying)
Award
Stock Option (Right to Buy)
2022-02-02+480,560→ 480,560 total
Exercise: $0.50Exp: 2029-12-29→ Common Stock (480,560 underlying)

Footnotes (7)

[F1]25% of the shares underlying the option vested or shall vest on July 23, 2016, and the remainder of the shares vested or shall vest in 48 equal monthly installments thereafter, starting August 23, 2016.
[F2]This option was issued pursuant to the terms of a business combination agreement involving the Issuer and GreenLight Biosciences, Inc. in exchange for a comparable option previously issued by such company.
[F3]20% of the shares underlying the option vested or shall vest on October 21, 2017, and the remainder of the shares vested or shall vest in 48 equal monthly installments thereafter, starting November 21, 2017.
[F4]20% of the shares underlying the option vested or shall vest on September 12, 2018, and the remainder of the shares vested or shall vest in 48 equal monthly installments thereafter, starting October 12, 2018.
[F5]20% of the shares underlying the option vested or shall vest on May 30, 2019, and the remainder of the shares vested or shall vest in 48 equal monthly installments thereafter, starting June 30, 2019.
[F6]20% of the shares underlying the option vested or shall vest on December 5, 2020 and the remainder of the shares vested or shall vest in 48 equal monthly installments thereafter, starting January 5, 2021.
[F7]25% of the shares underlying the option vested or shall vest on December 1, 2021 and the remainder of the shares vested or shall vest in 36 equal monthly installments thereafter, starting January 1, 2022.

Documents

1 file

GreenLight Biosciences Holdings, PBC

CIK 0001822691

Entity typeother